158 related articles for article (PubMed ID: 36549714)
21. A roadmap to precision treatments for familial pulmonary fibrosis.
Hurley K; Ozaki M; Philippot Q; Galvin L; Crosby D; Kirwan M; Gill DR; Alysandratos KD; Jenkins G; Griese M; Nathan N; Borie R;
EBioMedicine; 2024 Jun; 104():105135. PubMed ID: 38718684
[TBL] [Abstract][Full Text] [Related]
22. A Test to Comprehensively Capture the Known Genetic Component of Familial Pulmonary Fibrosis.
Villeneuve J; Tremblay É; Gaudreault N; Saavedra Armero V; Boudreau DK; Li Z; Renaut S; Dion G; Bossé Y
Am J Respir Cell Mol Biol; 2024 Jun; 70(6):437-445. PubMed ID: 38363828
[TBL] [Abstract][Full Text] [Related]
23. Lung transplant in patients with familial pulmonary fibrosis.
Bennett D; Fossi A; Lanzarone N; Vita E; Luzzi L; Paladini P; Bargagli E; Rottoli P; Sestini P
J Bras Pneumol; 2020; 46(6):e20200032. PubMed ID: 32725047
[TBL] [Abstract][Full Text] [Related]
24. The genetic and environmental causes of pulmonary fibrosis.
Macneal K; Schwartz DA
Proc Am Thorac Soc; 2012 Jul; 9(3):120-5. PubMed ID: 22802285
[TBL] [Abstract][Full Text] [Related]
25. Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis.
Kannengiesser C; Borie R; Ménard C; Réocreux M; Nitschké P; Gazal S; Mal H; Taillé C; Cadranel J; Nunes H; Valeyre D; Cordier JF; Callebaut I; Boileau C; Cottin V; Grandchamp B; Revy P; Crestani B
Eur Respir J; 2015 Aug; 46(2):474-85. PubMed ID: 26022962
[TBL] [Abstract][Full Text] [Related]
26. A common MUC5B promoter polymorphism and pulmonary fibrosis.
Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
[TBL] [Abstract][Full Text] [Related]
27. Adult-onset familial pulmonary fibrosis in Japanese brothers.
Yoshioka Y; Saiki S; Tsutsumi-Ishii Y; Koyama R; Hirashima N; Harada N; Yamasaki S; Suda K; Fukuchi Y
Pathol Int; 2004 Jan; 54(1):41-6. PubMed ID: 14674994
[TBL] [Abstract][Full Text] [Related]
28. Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study.
Rahaghi FF; Kolaitis NA; Adegunsoye A; de Andrade JA; Flaherty KR; Lancaster LH; Lee JS; Levine DJ; Preston IR; Safdar Z; Saggar R; Sahay S; Scholand MB; Shlobin OA; Zisman DA; Nathan SD
Chest; 2022 Jul; 162(1):145-155. PubMed ID: 35176276
[TBL] [Abstract][Full Text] [Related]
29. The Extent of Inflammatory Cell Infiltrate and Fibrosis in Lungs of Telomere- and Surfactant-Related Familial Pulmonary Fibrosis.
van Batenburg AA; van Oosterhout MFM; Knoppert SN; Kazemier KM; van der Vis JJ; Grutters JC; Goldschmeding R; van Moorsel CHM
Front Med (Lausanne); 2021; 8():736485. PubMed ID: 34631753
[TBL] [Abstract][Full Text] [Related]
30. [Genetic basis in chronic interstitial familial pneumopathy. Familial study of SFTPC].
Somaschini M; Cavazza A; Riva S; Sassi I; Carrera P
Pediatr Med Chir; 2005; 27(3-4):103-7. PubMed ID: 16910460
[TBL] [Abstract][Full Text] [Related]
31. Clinical features and genetic analysis of surfactant protein C in adult-onset familial interstitial pneumonia.
Setoguchi Y; Ikeda T; Fukuchi Y
Respirology; 2006 Jan; 11 Suppl():S41-5. PubMed ID: 16423270
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary Fibrosis and a TERT Founder Mutation With a Latency Period of 300 Years.
van der Vis JJ; van der Smagt JJ; Hennekam FAM; Grutters JC; van Moorsel CHM
Chest; 2020 Aug; 158(2):612-619. PubMed ID: 32315675
[TBL] [Abstract][Full Text] [Related]
33. Regulator of telomere length 1 (
Borie R; Bouvry D; Cottin V; Gauvain C; Cazes A; Debray MP; Cadranel J; Dieude P; Degot T; Dominique S; Gamez AS; Jaillet M; Juge PA; Londono-Vallejo A; Mailleux A; Mal H; Boileau C; Menard C; Nunes H; Prevot G; Quetant S; Revy P; Traclet J; Wemeau-Stervinou L; Wislez M; Kannengiesser C; Crestani B
Eur Respir J; 2019 Feb; 53(2):. PubMed ID: 30523160
[TBL] [Abstract][Full Text] [Related]
34. The genetic predisposition to interstitial lung disease: functional relevance.
du Bois RM
Chest; 2002 Mar; 121(3 Suppl):14S-20S. PubMed ID: 11893655
[No Abstract] [Full Text] [Related]
35. Genetic basis of familial interstitial lung disease: misfolding or function of surfactant protein C?
Whitsett JA
Am J Respir Crit Care Med; 2002 May; 165(9):1201-2. PubMed ID: 11991863
[No Abstract] [Full Text] [Related]
36. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin.
Verleden GM; du Bois RM; Bouros D; Drent M; Millar A; Müller-Quernheim J; Semenzato G; Johnson S; Sourvino G; Olivier D; Pietinalho A; Xaubet A
Eur Respir J Suppl; 2001 Sep; 32():17s-29s. PubMed ID: 11816821
[TBL] [Abstract][Full Text] [Related]
37. [Telomeres and lung].
Guérin C; Crestani B; Dupin C; Kawano-Dourado L; Ba I; Kannengiesser C; Borie R
Rev Mal Respir; 2022 Sep; 39(7):595-606. PubMed ID: 35715316
[TBL] [Abstract][Full Text] [Related]
38. Early interstitial lung disease in familial pulmonary fibrosis.
Rosas IO; Ren P; Avila NA; Chow CK; Franks TJ; Travis WD; McCoy JP; May RM; Wu HP; Nguyen DM; Arcos-Burgos M; MacDonald SD; Gochuico BR
Am J Respir Crit Care Med; 2007 Oct; 176(7):698-705. PubMed ID: 17641157
[TBL] [Abstract][Full Text] [Related]
39. Clustering of lung diseases in the family of interstitial lung disease patients.
Terwiel M; Grutters JC; van Moorsel CHM
BMC Pulm Med; 2022 Apr; 22(1):134. PubMed ID: 35392870
[TBL] [Abstract][Full Text] [Related]
40. Familial pulmonary fibrosis: a heterogeneous spectrum of presentations.
Hortense AB; Santos MKD; Wada D; Fabro AT; Lima M; Rodrigues S; Calado RT; Baddini-Martinez J
J Bras Pneumol; 2019 Jun; 45(5):e20180079. PubMed ID: 31188976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
